[Molecular copies of off-patent biologics that have become biosimilars: a new group recombinant products].
Institut für Pharmazeutische Biologie, Max-von-Laue-Str. 9, 60438 Frankfurt. dingermann@em.uni-frankfurt.de
Theo
T
Dingermann
Ilse
I
Zündorf
D001688:Biological Products; D059451:Biosimilar Pharmaceuticals / Q000737:chemistry / Q000494:pharmacology* / Q000627:therapeutic use; D016568:Drugs, Generic; D006801:Humans; D010330:Patents as Topic; D011994:Recombinant Proteins / Q000737:chemistry / Q000494:pharmacology* / Q000627:therapeutic use
D001688:Biological Products; D059451:Biosimilar Pharmaceuticals; D016568:Drugs, Generic; D011994:Recombinant Proteins